Khisimuzi Mdluli, Jr.,Cari M. Mendel,Eric Nuermberger
申请号：
US15765310
公开号：
US20180280401A1
申请日:
2016.10.05
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention relates to therapeutic combinations of anti-bacterial agents linezolid, bedaquiline and pretomanid, and optionally with pyrazinamide, in a short-course oral dosage regimen for the treatment of tuberculosis.
